WWP2 and prostate cancer: The results revealed that compared with normal tissues, WWP2 was significantly up-regulated in four tumor types: liver hepatocellular carcinoma (LIHC), cholangiocarcinoma (CHOL), prostate cancer (PRAD), and stomach adenocarcinoma (STAD).